Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: Estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine

Vaccine

Volumn 24, Issue 33-34, 2006, Pages 5960-5965

  Rendi Wagner, Pamela ^a   Kundi, Michael ^a   Mikolasek, Andrea ^a   Vécsei, Andreas ^b   Frühwirth, Martin ^c   Kollaritsch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Incidence; Pertussis; Surveillance; Vaccine effectiveness

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFANRIXHEXA; PERTUSSIS VACCINE; TETRAVAC;

ADOLESCENT; ARTICLE; AUSTRIA; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; WHOLE CELL;

ADOLESCENT; AGE FACTORS; AUSTRIA; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HOSPITALS; HUMANS; INCIDENCE; INFANT; PERTUSSIS VACCINE; POPULATION SURVEILLANCE; STATISTICS; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 33746076714     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.011     Document Type: Article

References (33)

1. Cherry J.D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United Sates: a comparative study. Curr Probl Pediatr 14 (1984) 1-78
2. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 16 4 Suppl (1997) S85-S89
3. Gzyl A., Augustynowicz E., Rabczenko D., Gniadek G., and Slusarczyk J. Pertussis in Poland. Int J Epidemiol 33 2 (2004) 358-365
4. Bass J.W., and Wittler R.R. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 13 (1994) 343-345
5. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., and Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290 (2003) 2968-2975
6. Baron S., Njamkepo E., Grimprel E., et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 17 (1998) 412-418
7. De Melker H.E., Schellekens J.F.P., Neppelenbroek S.E., Mooi F.R., Rümke H.C., and Conyn-van Spaendonck M.A.E. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Inf Dis 6 4 (2000) 348-357
8. Bundesministerium für Gesundheit und Frauen. Endgültiger Jahresausweis über angezeigte Fälle übertragbarer Krankheiten, 1946-2003, Austria. Available at: http://www.bmgf.gv.at.
9. Statistik Austria, Population Statistics. Available at: http://www.statistik.at/index.html.
10. Mary-Krause M., Mary J.Y., and Valleron A.J. Conditions of validation and use of the screening method for vaccine efficacy evaluation. Rev Epidemiol Sante Publ 41 (1993) 155-160
11. Orenstein W., Bernier R., and Hinman A. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 10 (1988) 212-241
12. Greenberg D.P., von König C.H., and Heininger U. Health burden of pertussis in infants and children. Pediatr Infect Dis J 24 5 (2005) S39-S43
13. Güris D., Strebel P.M., Bardenheier B., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults 1990-1996. Clin Infect Dis 28 (1999) 1230-1237
14. O'Brien J.A., and Caro J.J. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis 5 (2005) 57
15. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 296 (1988) 612-614
16. Qiushui H., Viljanen M.K., Nikkari S., Lyytikainnen R., and Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 170 (1994) 873-877
17. Lambert H.J. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 80 (1963) 365-369
18. Van Boven M., de Melker H.E., Schellekens J.F.P., and Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 164 (2000) 161-182
19. von König C.H.W., Campins-Marti M., Finn A., Guiso N., Mertsola J., and Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24 5 Suppl (2005) S87-S92
20. Forsyth K., Nagai M., Lepetic A., and Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24 5 Suppl (2005) S93-S97
21. Tan T., Halperin S., Cherry J.D., Edwards K., Englund J.A., Glezen P., et al. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J 24 5 Suppl (2005) S83-S86
22. Halperin S.A., Wang E.E.L., Law B., et al. Epidemiological features of pertussis in hospitalised patients in Canada 1991-1997: report of the immunization monitoring program-Active (IMPACT). Clin Infect Dis 28 (1999) 1238-1243
23. Juretzko P., von Kries R., Hermann M., von König C.H.W., Weil J., and Giani G. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany. Clin Infect Dis 35 (2002) 162-167
24. Greco D., Salmaso S., Manstrantonio P., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334 (1996) 341-348
25. Heininger U., Cherry J.D., Stehr K., et al. Comparative efficacy of the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine and Lederle whole-cell component DTP vaccine in German children after household exposure. Pediatrics 102 (1998) 546-553
26. Schmitt H.J., von König C.H.W., Neiss A., et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275 (1996) 37-41
27. Trollfors B., Taranger J., Lagergard T., et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333 (1995) 1045-1050
28. Fine P.E.M., and Clarkson J.A. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 9 (1987) 866-883
29. Walker E., Pinkerton I.W., Love W.C., Chaudhuri A.K.R., and Data J.B. Whooping cough in Glasgow 1969-1980. J Infect 3 (1981) 150-158
30. McKendrick M.W., Gully P.R., and Geddes A.M. Protection against pertussis by immunisation. Br Med J 281 (1980) 1390-1391
31. Farrington P. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22 (1993) 742-746
32. Muller F.M.C., Hoppe J.E., and von König C.H.W. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 35 (1997) 2435-2443
33. Meade B.D., and Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol 41 (1994) 51-55